Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Current Status and Issues of the Japan Oncofertility Registry.
Shigematsu K, Shimizu C, Furui T, Kataoka S, Kawai K, Kishida T, Kuwahara A, Maeda N, Makino A, Mizunuma N, Morishige KI, Nakajima TE, Ota K, Ono M, Shiga N, Tada Y, Takae S, Tamura N, Watanabe C, Yumura Y, Suzuki N, Takai Y. Shigematsu K, et al. Among authors: nakajima te. J Adolesc Young Adult Oncol. 2023 Aug;12(4):584-591. doi: 10.1089/jayao.2022.0110. Epub 2022 Dec 13. J Adolesc Young Adult Oncol. 2023. PMID: 36516123
Infusion site adverse events in breast cancer patients receiving highly emetic chemotherapy with prophylactic anti-emetic treatment with aprepitant and fosaprepitant: A retrospective comparison.
Tsuda T, Kyomori C, Mizukami T, Taniyama T, Izawa N, Horie Y, Hirakawa M, Ogura T, Nakajima TE, Tsugawa K, Boku N. Tsuda T, et al. Among authors: nakajima te. Mol Clin Oncol. 2016 Apr;4(4):603-606. doi: 10.3892/mco.2016.769. Epub 2016 Feb 5. Mol Clin Oncol. 2016. PMID: 27073673 Free PMC article.
Conventional versus traction-assisted endoscopic submucosal dissection for large esophageal cancers: a multicenter, randomized controlled trial (with video).
Yoshida M, Takizawa K, Nonaka S, Shichijo S, Suzuki S, Sato C, Komori H, Minagawa T, Oda I, Uedo N, Hirasawa K, Matsumoto K, Sumiyoshi T, Mori K, Gotoda T, Ono H; CONNECT-E Study Group. Yoshida M, et al. Gastrointest Endosc. 2020 Jan;91(1):55-65.e2. doi: 10.1016/j.gie.2019.08.014. Epub 2019 Aug 21. Gastrointest Endosc. 2020. PMID: 31445039 Clinical Trial.
Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment.
Mizukami T, Hamaji K, Onuki R, Yokomizo A, Nagashima Y, Takeda H, Umemoto K, Doi A, Arai H, Hirakawa M, Horie Y, Izawa N, Ogura T, Tsuda T, Sunakawa Y, Shibata M, Tanaka T, Mikami S, Nakajima TE. Mizukami T, et al. Among authors: nakajima te. Nutr Cancer. 2022;74(2):539-545. doi: 10.1080/01635581.2021.1902542. Epub 2021 Mar 23. Nutr Cancer. 2022. PMID: 33754895
Predictability of antitumor efficacy of cetuximab plus irinotecan based on skin rash severity according to observation period in patients with metastatic colorectal cancer following failure of fluorouracil, irinotecan and oxaliplatin.
Horie Y, Yamazaki K, Funakoshi T, Hamauchi S, Taniguchi H, Tsushima T, Todaka A, Machida N, Taku K, Fukutomi A, Onozawa Y, Yasui H, Mizukami T, Izawa N, Hirakawa M, Tsuda T, Nakajima T, Boku N. Horie Y, et al. Mol Clin Oncol. 2015 Sep;3(5):1029-1034. doi: 10.3892/mco.2015.586. Epub 2015 Jun 24. Mol Clin Oncol. 2015. PMID: 26623045 Free PMC article.
108 results